STUDY QUESTION: What are the data and trends on ART and IUI cycle numbers and their outcomes, and on fertility preservation (FP) interventions, reported in 2019 as compared to previous years? SUMMARY ANSWER: The 23rd ESHRE report highlights the rising ART treatment cycles and children born, alongside a decline in twin deliveries owing to decreasing multiple embryo transfers; fresh IVF or ICSI cycles exhibited higher delivery rates, whereas frozen embryo transfers (FET) showed higher pregnancy rates (PRs), and reported IUI cycles decreased while maintaining stable outcomes. WHAT IS KNOWN ALREADY: ART aggregated data generated by national registries, clinics, or professional societies have been gathered and analyzed by the European IVF-Monitoring (EIM) Consortium since 1997 and reported in a total of 22 manuscripts published in Human Reproduction and Human Reproduction Open. STUDY DESIGN, SIZE, DURATION: Data on medically assisted reproduction (MAR) from European countries are collected by EIM for ESHRE each year. The data on treatment cycles performed between 1 January and 31 December 2019 were provided by either national registries or registries based on initiatives of medical associations and scientific organizations or committed persons in one of the 44 countries that are members of the EIM Consortium. PARTICIPANTS/MATERIALS, SETTING, METHODS: Overall, 1487 clinics offering ART services in 40 countries reported, for the second time, a total of more than 1 million (1 077 813) treatment cycles, including 160 782 with IVF, 427 980 with ICSI, 335 744 with FET, 64 089 with preimplantation genetic testing (PGT), 82 373 with egg donation (ED), 546 with IVM of oocytes, and 6299 cycles with frozen oocyte replacement (FOR). A total of 1169 institutions reported data on IUI cycles using either husband/partner's semen (IUI-H; n = 147 711) or donor semen (IUI-D; n = 51 651) in 33 and 24 countries, respectively. Eighteen countries reported 24 139 interventions in pre- and post-pubertal patients for FP, including oocyte, ovarian tissue, semen, and testicular tissue banking. MAIN RESULTS AND THE ROLE OF CHANCE: In 21 countries (21 in 2018) in which all ART clinics reported to the registry 476 760 treatment cycles were registered for a total population of approximately 300 million inhabitants, allowing the best estimate of a mean of 1581 cycles performed per million inhabitants (range: 437-3621). Among the reporting countries, for IVF the clinical PRs per aspiration slightly decreased while they remained similar per transfer compared to 2018 (21.8% and 34.6% versus 25.5% and 34.1%, respectively). In ICSI, the corresponding PRs showed similar trends compared to 2018 (20.2% and 33.5%, versus 22.5% and 32.1%) When freeze-all cycles were not considered for the calculations, the clinical PRs per aspiration were 28.5% (28.8% in 2018) and 26.2% (27.3% in 2018) for IVF and ICSI, respectively. After FET with embryos originating from own eggs, the PR per thawing was at 35.1% (versus 33.4% in 2018), and with embryos originating from donated eggs at 43.0% (41.8% in 2018). After ED, the PR per fresh embryo transfer was 50.5% (49.6% in 2018) and per FOR 44.8% (44.9% in 2018). In IVF and ICSI together, the trend toward the transfer of fewer embryos continues with the transfer of 1, 2, 3, and ≥4 embryos in 55.4%, 39.9%, 2.6%, and 0.2% of all treatments, respectively (corresponding to 50.7%, 45.1%, 3.9%, and 0.3% in 2018). This resulted in a reduced proportion of twin delivery rates (DRs) of 11.9% (12.4% in 2018) and a similar triplet DR of 0.3%. Treatments with FET in 2019 resulted in twin and triplet DR of 8.9% and 0.1%, respectively (versus 9.4% and 0.1% in 2018). After IUI, the DRs remained similar at 8.7% after IUI-H (8.8% in 2018) and at 12.1% after IUI-D (12.6% in 2018). Twin and triplet DRs after IUI-H were 8.7% and 0.4% (in 2018: 8.4% and 0.3%) and 6.2% and 0.2% after IUI-D (in 2018: 6.4% and 0.2%), respectively. Eighteen countries (16 in 2018) provided data on FP in a total number of 24 139 interventions (20 994 in 2018). Cryopreservation of ejaculated sperm (n = 11 592 versus n = 10 503 in 2018) and cryopreservation of oocytes (n = 10 784 versus n = 9123 in 2018) were most frequently reported. LIMITATIONS, REASONS FOR CAUTION: Caution with the interpretation of results should remain as data collection systems and completeness of reporting vary among European countries. Some countries were unable to deliver data about the number of initiated cycles and/or deliveries. WIDER IMPLICATIONS OF THE FINDINGS: The 23rd ESHRE data collection on ART, IUI, and FP interventions shows a continuous increase of reported treatment numbers and MAR-derived livebirths in Europe. Although it is the largest data collection on MAR in Europe, further efforts toward optimization of both the collection and the reporting, from the perspective of improving surveillance and vigilance in the field of reproductive medicine, are awaited. STUDY FUNDING/COMPETING INTEREST(S): The study has received no external funding and all costs are covered by ESHRE. There are no competing interests.

Center for Reproductive Medicine University of Antwerp Antwerp University Hospital Edegem Belgium

Cliniques universitaires Saint Luc Université Catholique de Louvain Brussels Belgium

Department of Gynaecology Obstetrics and Neonatology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Obstetrics and Gynecology Institute of Clinical Sciences Göteborg University Göteborg Sweden

Department of Obstetrics and Gynecology University Hospital LMU Munich Munich Germany

Elisabeth Twee Steden Ziekenhuis Tilburg The Netherlands

ESHRE Central Office Grimbergen Belgium

Fertility Center Berlin Berlin Germany

Hospital General Universitario de Valencia Valencia Spain

National Transplant Agency Bukarest Romania

Reproductive Medicine and Gynecological Endocrinology University Hospital University of Basel Basel Switzerland

Zobrazit více v PubMed

Braat DDM, Schutte JM, Bernardus RE, Mooij TM, van Leeuwen FE.. Maternal death related to IVF in the Netherlands 1984-2008. Hum Reprod 2010;25:1782–1786. PubMed

Calhaz-Jorge C, De Geyter C, Kupka MS, Wyns C, Mocanu E, Motrenko T, Scaravelli G, Smeenk J, Vidakovic S, Goossens V.. Survey on ART and IUI: legislation, regulation, funding and registries in European countries: the European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod Open 2020;2020:hoz044. PubMed PMC

Chambers GM, Dyer S, Zeger-Hochschild F, de Mouzon J, Ishihara O, Banker M, Mansour R, Kupka MS, Adamson GD.. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014. Hum Reprod 2021;36:2921–2934. PubMed

Cornelisse S, Fleischer K, Arends B, Brink-van der Vlugt JJ, De Bruin JP, Curfs MHJM, Derhaag JG, Deurloo KL, Van Dongen AJCM, Van Echten-Arends J. et al. The ToF-study – comparing the cumulative live birth rate of blastocyst-stage versus cleavage-stage embryo transfers in good prognosis IVF patients: a multicenter randomized controlled trial. Hum Reprod 2023;38:dead093.005.

De Geyter C, Calhaz-Jorge C, Goossens V, Magli CM, Smeenk J, Vesela K, Vermeulen N, Wyns C.. EuMAR: a roadmap towards a prospective, cycle-by-cycle registry of medically assisted reproduction in Europe. Hum Reprod Open 2023;2023:hoad011. PubMed PMC

De Geyter C, Calhaz-Jorge C, Kupka MS, Wyns C, Mocanu E, Motrenko T, Scaravelli G, Smeenk J, Vidakovic S, Goossens V; European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). ART in Europe, 2015: results generated from European registries by ESHRE. Hum Reprod Open 2020a;2020:hoaa038. PubMed PMC

De Geyter C, Wyns C, Calhaz-Jorge C, de Mouzon J, Ferraretti AP, Kupka M, Nyboe Andersen A, Nygren KG, Goossens V.. 20 years of the European IVF-Monitoring Consortium registry: what have we learned? A comparison with registries from two other regions. Hum Reprod 2020b;35:2832–2849. PubMed PMC

De Geyter C, Wyns C, Mocanu E, de Mouzon J, Calhaz-Jorge C.. Data collection systems in ART must follow the pace of change in clinical practice. Hum Reprod 2016;31:2160–2163. PubMed

De Neubourg D, Bogaerts K, Blockeel C, Coetsier T, Delvigne A, Devreker F, Dubois M, Gillain N, Gordts S, Wyns C.. How do cumulative live birth rates and cumulative multiple live birth rates over complete courses of assisted reproductive technology treatment per woman compare among registries? Hum Reprod 2016;31:93–99. PubMed

Ferraretti AP, Nygren K, Nyboe Andersen A, de Mouzon J, Kupka M, Calhaz-Jorge C, Wyns C, Gianaroli L, Goossens V.. European IVF-Monitoring Consortium (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Trends over 15 years in ART in Europe: an analysis of 6 million cycles. Hum Reprod Open 2017;2017:hox012. PubMed PMC

Glujovsky D, Marta A, Retamar Q, Alvarez Sedo CR, Ciapponi A, Cornelisse S, Blake D.. Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology Cochrane Database. Syst Rev 2022;5:CD002118. PubMed PMC

Kissin DM, Adamson GD, Chambers G, De Geyter C, eds. Assisted Reproductive Technology Surveillance. Cambridge: Cambridge University Press, 2019.

Land JA, Evers JL.. Risks and complications in assisted reproduction techniques: report of an ESHRE consensus meeting. Hum Reprod 2003;18:455–457. PubMed

Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology. Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion. Fertil Steril 2018;110:1246–1252. PubMed

Roque M, Nóbrega BN, Valle M, Sampaio M, Geber S, Haahr T, Humaidan P, Esteves SC.. Freeze-all strategy in IVF/ICSI cycles: an update on clinical utility. Panminerva Med 2019;61:52–57. PubMed

Spinella F, Bronet F, Carvalho F, Coonen E, De Rycke M, Rubio C, Goossens V, Van Montfoort A.. ESHRE PGT Consortium data collection XXI: PGT analyses in 2018. Hum Repr Open 2023;2023:hoad010. PubMed PMC

Wyns C, Bergh C, Calhaz-Jorge C, De Geyter C, Kupka MS, Motrenko T, Rugescu I, Smeenk J, Tandler-Schneider A, Vidakovic S. et al.; European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). ART in Europe, 2016: results generated from European registries by ESHRE. Hum Reprod Open 2020;2020:hoaa032. PubMed PMC

Wyns C, De Geyter C, Calhaz-Jorge C, Kupka MS, Motrenko T, Smeenk J, Bergh C, Tandler-Schneider A, Rugescu I, Vidakovic S. et al.; European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). ART in Europe, 2017: results generated from European registries by ESHRE. Hum Reprod Open 2021;2021:hoab026. PubMed

Wyns C, De Geyter C, Calhaz-Jorge C, Kupka MS, Motrenko T, Smeenk J, Bergh C, Tandler-Schneider A, Rugescu I, Goossens V, European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). ART in Europe, 2018: results generated from European registries by ESHRE. Hum Reprod Open, 2022;2022:hoac022. PubMed

Zaat T, Zagers M, Mol F, Goddijn M, van Wely M, Mastenbroek S.. Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database Syst Rev 2021;2:CD011184. PubMed PMC

Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke ID. et al. The International Glossary on Infertility and Fertility Care, 2017. Hum Reprod 2017;32:1786–1801. PubMed PMC

How great thou ART: biomechanical properties of oocytes and embryos as indicators of quality in assisted reproductive technologies